Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company which is developing a pipeline of proprietary pharmacological abuse deterrent opioid products as well as niche generic products. Elite specializes in oral sustained and controlled release drug products which have high barriers to entry. Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddy s Laboratories and Valeant Pharmaceuticals International. Elite currently has nine commercial products being sold, four products under review pending approval by the FDA, additional approved products pending manufacturing site transfer and the NDA filing for SequestOx . Elite s lead pipeline products include abuse deterrent opioids which utilize the Company s patented proprietary technology and a once daily opioid. These products include sustained release oral formulations of opioids for the treatment of chronic pain. These formulations are intended to address two major limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential opioid abuse. Elite also provides contract manufacturing for Ascend Laboratories a subsidiary of Alkem Laboratories Ltd. . Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. Learn more at www.elitepharma.com.
Quote | Elite Pharmaceuticals Inc. (OTCMKTS:ELTP)
Last: | $0.15434 |
---|---|
Change Percent: | -1.9% |
Open: | $0.1559 |
Close: | $0.15434 |
High: | $0.1559 |
Low: | $0.148 |
Volume: | 497,297 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Elite Pharmaceuticals Inc. (OTCMKTS:ELTP)
2024-02-15 14:44:02 ET Elite Pharmaceuticals, Inc. (ELTP) Q3 2024 Earnings Conference Call February 15, 2023, 11:30 AM ET Company Participants Nasrat Hakim - President and Chief Executive Officer Carter Ward - Chief Financial Officer, Secretary, and Treasurer P...
2024-02-14 16:57:13 ET More on Elite Pharmaceuticals Elite Pharmaceuticals, Inc. (ELTP) Q2 2024 Earnings Call Transcript Financial information for Elite Pharmaceuticals Read the full article on Seeking Alpha For further details see: Elite Pharmaceuticals ...
Message Board Posts | Elite Pharmaceuticals Inc. (OTCMKTS:ELTP)
Subject | By | Source | When |
---|---|---|---|
Shark, Appreciate all the good work you do for | littlerhody | investorshub | 05/01/2023 11:56:21 AM |
https://finance.yahoo.com/news/lannett-company-inc-enters-restructuring-105500074.html Good news | sharkey1 | investorshub | 05/01/2023 11:24:44 AM |
DollarLand then organic growth to the NASDAQ | NASDAQ2020 | investorshub | 05/01/2023 10:51:09 AM |
So Nasrat doesn't care about himself? | aELmTPa | investorshub | 05/01/2023 3:32:58 AM |
Yep .20 just like I said... | aELmTPa | investorshub | 05/01/2023 3:31:11 AM |
News, Short Squeeze, Breakout and More Instantly...
Elite Pharmaceuticals Inc. Company Name:
ELTP Stock Symbol:
OTCMKTS Market:
Elite Pharmaceuticals Inc. Website:
Conference Call Scheduled for Thursday, February 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / February 14, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCBB:ELTP), a specialty pharmaceutical company engaged in the development, manufacture, and distribution of niche gener...
ESSA Pharma Inc. (EPIX) is expected to report $-0.17 for Q1 2024 QuidelOrtho Corp Com (QDEL) is expected to report $2.01 for Q4 2023 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 Portsmouth Square, Inc. (PRSI) is expected to report for Q2 2024 Similarweb Ltd. (SMWB) ...
Financials for Third Quarter Fiscal Year 2024 Ended December 31, 2023 will be released on February 14, 2024 NORTHVALE, NJ / ACCESSWIRE / February 8, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic product...